Earnings, Q2 FY2026
Strong Q2 driven by 3870 pump demand; bookings, backlog, and guidance all point to robust growth.
IRadimed Corp.
No trades
No trades
Documents
2026
Jul 31, 2026
Earnings, Q1 FY2026
Record Q2 revenue and FDA clearance of new pump drive raised 2025 outlook and future growth.
2025
Earnings, Q4 FY2025
AnnualRecord Q4 revenue and strong margins set the stage for major growth with the 3870 pump launch.
Earnings, Q3 FY2025
Record Q2 results and FDA clearance of new pump drive raised outlook and strong future growth.
Earnings, Q2 FY2025
Record Q2 results and FDA-cleared 3870 pump drive raised outlook and strong future growth.
Earnings, Q1 FY2025
Q1 2025 delivered record revenue and earnings, with strong pump and disposable growth.
43rd Annual J.P. Morgan Healthcare Conference 2025
New MRI-safe IV pump launch and facility expansion set stage for rapid multi-year growth.
2024
Earnings, Q4 FY2024
AnnualRecord revenue and earnings growth driven by pumps, with strong 2025 outlook and stable margins.
Earnings, Q3 FY2024
Record Q3 revenue and raised 2024 guidance, with strong pump sales and margin performance.
Earnings, Q2 FY2024
Record Q2 revenue and margin growth driven by strong pump sales and robust outlook.
Earnings, Q1 FY2024
Lytham Partners 2024 Select Conference
J.P. Morgan 42nd Annual Healthcare Conference 2024
2023
Earnings, Q4 FY2023
AnnualEarnings, Q3 FY2023
Earnings, Q2 FY2023
Earnings, Q1 FY2023
2022
Earnings, Q4 FY2022
AnnualEarnings, Q3 FY2022
Earnings, Q2 FY2022
Earnings, Q1 FY2022
2021
Earnings, Q4 FY2021
AnnualEarnings, Q3 FY2021
2020
Earnings, Q4 FY2020
Annual